Ownership and insider activity for None (ALLR): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Allarity Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing new cancer treatments. They utilize a unique "drug response predictor" technology to generate specific companion diagnostics, aiming to identify which patients will best respond to their various oncology therapeutics.
Price
| Price | $1.16 |
| Market Cap | $18M |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-01-28 | Jensen Thomas | A-Award | 200,000 | |
| 2026-01-07 | Hoeiland Jesper | A-Award | 25,000 | |
| 2025-06-10 | Hoeiland Jesper | |||
| 2026-01-28 | McLaughlin Gerald W. | A-Award | 45,000 | |
| 2026-01-28 | Graff Jeremy R. | A-Award | 133,333 | |
| 2026-01-28 | Ervin Jeffrey S | A-Award | 150,000 | |
| 2026-01-07 | Graff Jeremy R. | A-Award | 133,333 | |
| 2025-09-30 | Graff Jeremy R. | M-Exempt | 39,494 | |
| 2025-09-30 | Graff Jeremy R. | M-Exempt | 39,494 | |
| 2025-09-30 | Graff Jeremy R. | F-InKind | 14,613 | $23K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $2.1M | $536027 | $237378 | $1.5M | $298000 | $19.6M | $2.0M | $166000 | $19.5M | $14.7M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | $350000 | 0 | 0 | 0 | 0 |
| Receivables | $2306 | $407742 | 0 | $1.7M | $1.1M | $1.3M | $871000 | $946000 | $2.2M | $895000 |
| Inventory | $34694 | $168898 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | $4.4M | $1.3M | $2.2M | $3.3M | $1.7M | $21.4M | $5.0M | $2.0M | $22.3M | $17.9M |
| Property, Plant & Equipment | $68509 | $21757 | $55700 | $437000 | $352000 | $94000 | $27000 | $20000 | $309000 | $330000 |
| Goodwill | $1.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | $158868 | 0 | $36.3M | $27.7M | $30.5M | $28.1M | $9.5M | $9.9M | 0 | 0 |
| Total Assets | $6.5M | $2.1M | $38.6M | $31.6M | $33.4M | $49.6M | $14.5M | $11.9M | $22.6M | $18.3M |
| Accounts Payable | $1.3M | $472368 | $1.9M | $2.2M | 0 | $698000 | $6.3M | $8.4M | $4.2M | $4.3M |
| Short-term Debt | 0 | 0 | $2.9M | $536000 | $1.5M | 0 | $2.6M | $1.3M | $1.4M | $1.4M |
| Total Current Liabilities | $1.3M | $1.7M | $5.4M | $4.7M | $5.5M | $20.7M | $11.2M | $14.2M | $10.8M | $8.4M |
| Long-term Debt | 0 | 0 | 0 | 0 | $880000 | $979000 | $1.1M | 0 | 0 | 0 |
| Total Liabilities | $1.3M | $1.7M | $10.7M | $10.7M | $9.0M | $30.8M | $12.7M | $14.6M | $10.8M | $8.4M |
| Retained Earnings | 0 | -$7.1M | -$9.4M | -$32.4M | -$39.8M | -$66.5M | -$82.5M | -$94.5M | -$119.0M | -$130.2M |
| Total Equity | $5.2M | $394043 | $23.8M | $18.1M | $24.4M | $18.8M | $1.9M | -$2.8M | $11.8M | $9.8M |
| Total Debt | 0 | 0 | $2.9M | $963000 | $2.7M | $1.1M | $3.7M | $1.3M | $1.4M | $1.4M |
| Net Debt | -$2.1M | -$536027 | $2.7M | -$561000 | $2.4M | -$18.8M | $1.7M | $1.1M | -$18.2M | -$13.3M |
| Working Capital | $3.0M | -$392915 | -$3.2M | -$1.4M | -$3.8M | $685000 | -$6.3M | -$12.2M | $11.5M | $9.5M |
Financial Health
| Piotroski F-Score | 4 |
| Altman Z-Score | -10.51 |
Related companies: BCTX · CASI · CING · CLSD · CRIS · ENTO · KAPA
More sections of ALLR: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks